Accelerated Pharma (Accelerated Pharma) Operating Cash Flow per Share : $-0.25 (TTM As of Mar. 2017)

View and export this data going back to 2016. Start your Free Trial

What is Accelerated Pharma Operating Cash Flow per Share?

Accelerated Pharma's operating cash flow per share for the three months ended in Mar. 2017 was $-0.04. Accelerated Pharma's operating cash flow per share for the trailing twelve months (TTM) ended in Mar. 2017 was $-0.25.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the OCF Growth Rate using Operating Cash Flow per Share data.

The historical rank and industry rank for Accelerated Pharma's Operating Cash Flow per Share or its related term are showing as below:

ACCP's 3-Year OCF Growth Rate is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 6.95
* Ranked among companies with meaningful 3-Year OCF Growth Rate only.

Accelerated Pharma Operating Cash Flow per Share Historical Data

The historical data trend for Accelerated Pharma's Operating Cash Flow per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accelerated Pharma Operating Cash Flow per Share Chart

Accelerated Pharma Annual Data

Trend

Dec14

Dec15

Dec16

Operating Cash Flow per Share

-0.28

Accelerated Pharma Quarterly Data
	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17
Operating Cash Flow per Share	Get a 7-Day Free Trial			-0.06	-0.10	-0.09	-0.03	-0.04

Competitive Comparison of Accelerated Pharma's Operating Cash Flow per Share

For the Drug Manufacturers - Specialty & Generic subindustry, Accelerated Pharma's Price-to-Operating-Cash-Flow, along with its competitors' market caps and Price-to-Operating-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Accelerated Pharma's Price-to-Operating-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Accelerated Pharma's Price-to-Operating-Cash-Flow distribution charts can be found below:

* The bar in red indicates where Accelerated Pharma's Price-to-Operating-Cash-Flow falls into.

Accelerated Pharma Operating Cash Flow per Share Calculation

Operating Cash Flow per Share is the amount of Cash Flow from Operations per outstanding share of the company's stock.

Accelerated Pharma's Operating Cash Flow per Share for the fiscal year that ended in Dec. 2016 is calculated as

Operating Cash Flow per Share (A: Dec. 2016 )	=	Cash Flow from Operations (A: Dec. 2016 )	/	Shares Outstanding (Diluted Average) (A: Dec. 2016 )
	=	-1.919	/	6.889
	=	-0.28

Accelerated Pharma's Operating Cash Flow per Share for the quarter that ended in Dec. 2016 is calculated as

Operating Cash Flow per Share (Q: Mar. 2017 )	=	Cash Flow from Operations (Q: Mar. 2017 )	/	Shares Outstanding (Diluted Average) (Q: Mar. 2017 )
	=	-0.24	/	6.89
	=	-0.03

Operating Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2017 adds up the quarterly data reported by the company within the most recent 12 months, which was $-0.25

Accelerated Pharma Operating Cash Flow per Share Related Terms

Thank you for viewing the detailed overview of Accelerated Pharma's Operating Cash Flow per Share provided by GuruFocus.com. Please click on the following links to see related term pages.

Accelerated Pharma (Accelerated Pharma) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Accelerated Pharma Inc (NAS:ACCP) » Definitions » Operating Cash Flow per Share

Comparable Companies

Traded in Other Exchanges

N/A

Address

Website

Accelerated Pharma Inc, is a Delaware corporation organized on May 12, 2014. It is a biopharmaceutical company focused on utilizing its genomic technology to enhance the development and commercialization of pharmaceutical products. Its lead product candidate is Picoplatin, a new generation platinum-based cancer therapy that has the potential for use in different formulations, as a single agent or in combination with other anti-cancer agents, to treat multiple cancer indications.

Accelerated Pharma (Accelerated Pharma) Headlines

No Headlines